GCTresearch Archives

Ride for Research 2024: Join the Cause Today!

Ride for Research 2024 is an upcoming event for ROC Inc and lead by board member Peter Reaburn. The event aims to raise vital funds and awareness for rare ovarian cancer research. The team of 30 riders will cycle for over five consecutive days starting from March 18th, 2024 in Bright Victoria. Currently, they have raised $83,000 out of their $200,000 goal with only 70 days left. Donating to one of the riders and providing words of encouragement is a great way to show support and make a difference. Join the cause and help make a positive impact!

ROC Inc Ride 4 Research March 18-22 March 2024 Call out for riders to join in

Come join our unique event in beautiful Bright, Victoria 18-22 March 2024. An unforgettable experience! This ride is not only about the joy of cycling, but also about supporting a meaningful cause to raise money to support rare ovarian cancer awareness and research. Choose to do a challenging road ride one day, a scenic rail trail the next. The choice is yours. Check out our website for details: https://www.rocinc.org.au/ride-for-research/ The 2024 ROC Inc Ride 4 Research raises money for Rare Ovarian Cancer awareness and research Together, we are raising funds to make a positive impact in our community and beyond. […]

Expressing Gratitude to the Lakeview Hotel Motel and Our Patrons for Supporting ROC Inc.

We extend our sincere gratitude to the Lakeview Hotel Motel and its patrons who are members and have pledged their community points to ROC Inc. By simply being a member, you can earn community points every time you visit. Thus far, members have pledged over $7,000, and we cannot thank you enough. Please note that the current period for pledging your points to ROC Inc will end on December 24th. Join us in supporting ovarian cancer research and awareness by pledging to ROC Inc. If you are not already a member, sign up at the Lakeview Hotel and become a […]

Rare Ovarian Cancer researchers and consumers work together to produce a research paper.

Congratulations to ALL of the authors, lead author Professor Victoria White from Deakin University, Professor Peter Fuller, Associate Professor Simon Chu, Maria Alexiadia, All from the Hudson Institute of Medical Research, Professor Thomas Jobling from Monash Health, Members from the GCT Survivor Sister Facebook Group our Founder and CEO of ROC Inc Natasha Armour (from Australia), Linda Langdale (from the UK), Sue Rogers, Kaye Ackermann and Kim Eroh (all from the USA), on having your research paper published in the journal Cancer – an international interdisciplinary journal of the American Cancer Society https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.34767 You should ALL feel proud of your […]

The ride COVID couldn’t stop – Ride 4 Research 2022 for Rare Ovarian Cancer Research

Ride 4 Research 2022 (R4R) riders have completed the last leg of the ride on Saturday 18 June 2022. 12 riders lead by R4R organiser Peter Reaburn set out from Canberra on 30 April to cycle 900km in 9 days, however the ride was cut short by two days as there was a COVID outbreak among the riders and support crew. Each of the riders completed the final distance in their own State joined by family and friends A huge congratulation and heartfelt thank you to all the riders, support crew, supporters, major sponsors and to all of you who […]

11-month-old baby Neve’s ovarian tumour was bigger than a softball.

11-month-old baby Neve’s ovarian tumour was bigger than a softball. Imagine being diagnosed with ovarian cancer as a baby. Unfortunately, this was the confronting reality Neve and her parents Jo and Zoe found themselves in on August 1, 2014. Aged just 11 months old, Neve was diagnosed with Juvenile Granulosa Cell Tumour (jGCT) – a recurrent, incurable ovarian cancer that has no effective treatments available post-surgery. Most people associate ovarian cancer as a disease affecting adult women. Few people know that ovarian cancer can be diagnosed at any age and affects females of all ages. So little is known about […]